Ashland Inc. (ASH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ashland Inc. (ASH) trades at $67.21 with AI Score 49/100 (Grade C). Ashland Inc. is a global specialty chemicals company providing additives and ingredients for various industries. Market cap: $3.08B, Sector: Basic materials.
Price live · AI analysis from May 10, 2026ASH stock analysis for 2026: Analysts have set a consensus price target of $68.29 for Ashland Inc., suggesting 1.6% upside from the current price of $67.21. The AI MoonshotScore is 49/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
ASH: the 1 perspectives are evenly split.
How is this calculated? →Ashland Inc. (ASH) Materials & Commodity Exposure
Ashland Inc. provides specialty additives and ingredients across diverse sectors, including life sciences, personal care, and specialty additives. With a focus on innovation and sustainability, Ashland serves a global clientele, offering tailored solutions and maintaining a significant presence in the specialty chemicals market, with a dividend yield of 3.02%.
What Is the Investment Thesis for ASH?
Ashland Inc. presents a compelling investment thesis based on its strategic focus on high-margin specialty chemicals, diverse end-market exposure, and commitment to innovation. With a market capitalization of $3.08B, Ashland's growth is underpinned by its Life Sciences and Personal Care segments, which benefit from secular trends in healthcare and consumer preferences for sustainable products. The company's dividend yield of 3.02% offers an attractive income stream for investors. However, investors should be aware of the company's negative profit margin of -39.0%. Upcoming catalysts include continued expansion in high-growth markets and successful integration of strategic acquisitions. Potential risks include raw material price volatility and economic downturns affecting demand in key end markets.
Based on FMP financials and quantitative analysis
ASH Key Highlights
- Market capitalization of $3.08B, reflecting its established position in the specialty chemicals market.
- Dividend yield of 3.02%, providing an attractive income stream for investors.
- Gross margin of 25.2%, indicating the company's ability to generate profit from its sales after accounting for the cost of goods sold.
- Beta of 0.40, suggesting lower volatility compared to the overall market.
- Operates through four segments: Life Sciences, Personal Care & Household, Specialty Additives, and Intermediates and Solvents, providing diversification across end markets.
Who Are ASH's Competitors?
ASH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CC The Chemours Company | $18.32 | -3.63% | $2.75B | 40 |
| MEOH Methanex Corporation | $44.05 | -3.12% | $3.41B | 49 |
| SKE Skeena Resources Limited | $28.29 | -1.43% | $3.51B | 52 |
| AVNT Avient Corporation | $38.83 | +4.07% | $3.56B | 62 |
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ASH's Key Strengths?
- Diverse product portfolio catering to multiple end markets.
- Strong focus on innovation and research and development.
- Established relationships with key customers.
- Global presence and distribution network.
What Are ASH's Weaknesses?
- Negative profit margin of -39.0%.
- Exposure to raw material price volatility.
- Dependence on economic conditions in key end markets.
- Potential challenges in integrating strategic acquisitions.
What Could Drive ASH Stock Higher?
- Continued expansion in high-growth markets such as nutraceuticals and sustainable personal care.
- Successful integration of strategic acquisitions to expand product portfolio and geographic reach.
- Development and commercialization of innovative advanced materials.
- Increasing demand for sustainable and bio-based chemicals driving growth in key segments.
What Are the Key Risks for ASH?
- Financial-distress signal — its Altman Z-Score of 1.61 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-37.5%) — the business is not currently generating profit on shareholder capital.
- Economic downturns affecting demand in key end markets.
- Raw material price volatility impacting profitability.
- Increased competition from existing and new players in the specialty chemicals industry.
- Changes in environmental regulations increasing compliance costs.
- Disruptions in supply chains affecting production and distribution.
What Are the Growth Opportunities for ASH?
- Expansion in Life Sciences: Ashland's Life Sciences segment is poised for growth, driven by increasing demand for pharmaceutical, nutrition, and nutraceutical solutions. The global nutraceuticals market is projected to reach $500 billion by 2028, presenting a significant opportunity for Ashland to expand its product offerings and market share. The company's expertise in controlled release polymers and custom formulation positions it well to capitalize on this trend. Timeline: Ongoing.
- Sustainable Personal Care Ingredients: The growing consumer preference for sustainable and bio-based personal care products presents a significant growth opportunity for Ashland's Personal Care & Household segment. The global market for natural and organic personal care products is projected to reach $48 billion by 2027. Ashland's range of nature-based and biodegradable ingredients positions it well to capture this market share. Timeline: Ongoing.
- Specialty Additives for Construction: The construction industry's increasing demand for high-performance materials and sustainable solutions drives growth in Ashland's Specialty Additives segment. The global construction chemicals market is projected to reach $60 billion by 2028. Ashland's rheology modifiers and foam control agents cater to this demand, offering improved performance and environmental benefits. Timeline: Ongoing.
- Strategic Acquisitions: Ashland can pursue strategic acquisitions to expand its product portfolio, geographic reach, and technological capabilities. Identifying and integrating complementary businesses can accelerate growth and enhance Ashland's competitive position. Potential acquisition targets include companies with innovative technologies in specialty chemicals and additives. Timeline: Ongoing.
- Innovation in Advanced Materials: Investing in research and development to create advanced materials with unique properties and applications can drive growth in Ashland's Specialty Additives segment. The market for advanced materials is projected to reach $100 billion by 2028. Ashland's expertise in advanced ceramics and thermoplastic metals positions it well to develop innovative solutions for various industries. Timeline: Ongoing.
What Opportunities Does ASH Have?
- Expansion in high-growth markets such as nutraceuticals and sustainable personal care.
- Strategic acquisitions to expand product portfolio and geographic reach.
- Development of innovative advanced materials.
- Increasing demand for sustainable and bio-based chemicals.
What Threats Does ASH Face?
- Economic downturns affecting demand in key end markets.
- Increased competition from existing and new players.
- Changes in environmental regulations.
- Disruptions in supply chains.
What Are ASH's Competitive Advantages?
- Specialized Expertise: Ashland's deep expertise in specialty chemicals and additives provides a competitive advantage.
- Strong Customer Relationships: Long-standing relationships with key customers create a barrier to entry for competitors.
- Innovation and R&D: Continuous investment in research and development drives innovation and product differentiation.
- Diverse Product Portfolio: A broad range of products and solutions caters to diverse end markets, reducing reliance on any single industry.
What Does ASH Do?
Founded in 1924 and headquartered in Wilmington, Delaware, Ashland Inc. has evolved from an oil refining company to a global leader in specialty chemicals. Initially focused on crude oil refining, Ashland strategically shifted its focus to specialty additives and ingredients, catering to a diverse range of industries. This transformation involved divesting its petroleum operations and investing in high-margin specialty chemicals businesses. Today, Ashland operates through four key segments: Life Sciences, Personal Care & Household, Specialty Additives, and Intermediates and Solvents. The Life Sciences segment offers solutions for pharmaceutical, nutrition, and nutraceutical applications. The Personal Care & Household segment provides ingredients for personal care products and household supplies. The Specialty Additives segment offers products for coatings, construction, energy, and other industrial markets. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives. Ashland serves customers worldwide, providing tailored solutions and maintaining a strong presence in the specialty chemicals market. The company's strategic focus on innovation, sustainability, and customer collaboration has solidified its position as a key player in the industry.
What Products and Services Does ASH Offer?
- Provides pharmaceutical solutions, including controlled release polymers and tablet coatings.
- Offers nutrition solutions, such as thickeners, stabilizers, and emulsifiers.
- Supplies nutraceutical solutions for weight management, joint comfort, and sports nutrition.
- Provides nature-based and biodegradable ingredients for personal care products.
- Offers rheology modifiers, foam control agents, and surfactants for industrial applications.
- Produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone.
How Does ASH Make Money?
- Develops and manufactures specialty additives and ingredients.
- Sells products to customers in various industries, including pharmaceuticals, personal care, and construction.
- Provides custom formulation and toll processing services.
- Generates revenue through product sales and service fees.
What Industry Does ASH Operate In?
Ashland Inc. operates within the specialty chemicals industry, a sector characterized by innovation, customization, and high value-added products. The industry is driven by trends such as increasing demand for sustainable and bio-based chemicals, growing healthcare and personal care markets, and stricter environmental regulations. Ashland competes with companies like The Chemours Company (CC), Methanex Corporation (MEOH), Avient Corporation (AVNT), and Skeena Resources Limited (SKE). The specialty chemicals market is projected to grow at a steady pace, driven by increasing demand from emerging economies and technological advancements. Ashland's focus on innovation and customer collaboration positions it well to capitalize on these trends.
Who Are ASH's Key Customers?
- Pharmaceutical companies
- Personal care product manufacturers
- Food and beverage companies
- Construction companies
- Industrial manufacturers
FY2026 estForward Outlook
Wall Street analysts project Ashland Inc. revenue of about $1.85B for fiscal 2026, with EPS near $3.60. The estimate reflects 9 contributing analysts.
F-Score 4/9Financial Health
Ashland Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.61 places it in the distress zone, a signal of elevated financial risk.
ROE -38%Key Financial Metrics
Return on equity for Ashland Inc. stands at -37.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -15.7%, showing how much profit it generates from its asset base. Its free cash flow yield is 11.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.06 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -23.8%, the inverse of the P/E and a quick read on earnings relative to price.
Ashland Inc. (ASH) Valuation Context
Valued at $3.08B, ASH is classified as a mid-cap stock. Relative to its peer group, ASH's quantitative score of 49/100 is roughly in line with the peer average of 54/100.
ASH Revenue & Earnings Trend
In Q1 2026, ASH generated $482.0M in top-line revenue, marking a sequential increase of 24.9%. The company recorded net income of $16.0M, with diluted EPS of $0.34. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Basic Materials. Across the four most recent quarters, ASH averaged $-3.84 in diluted EPS.
Company Profile
Ashland Inc. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Wilmington, US. The company is led by CEO Guillermo Novo. ASH has traded publicly since 1980.
ASH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Ashland's future performance, indicating that key stakeholders believe in the company's potential.
- Community sentiment has shifted positively, with discussions highlighting Ashland's innovative product lines and their relevance in sustainable solutions.
- Analysts are noting that Ashland's strategic partnerships are strengthening its market position, enhancing growth opportunities in key sectors.
- The company's focus on expanding its specialty chemicals portfolio aligns well with current market trends, fostering optimism among investors.
Bear Case
- Concerns have emerged regarding supply chain disruptions that could impact Ashland's operational efficiency and cost structure in the near term.
- Social sentiment reflects caution, with some community members expressing doubts about the sustainability of recent growth trends.
- Recent market developments show increased competition in the specialty chemicals space, which could pressure Ashland's market share.
- There are apprehensions about potential regulatory changes that may affect Ashland's operations, leading to uncertainty among investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $482M | $16M | $0.34 |
| Q4 2025 | $386M | -$12M | -$0.26 |
| Q3 2025 | $478M | $32M | $0.70 |
| Q2 2025 | $463M | -$742M | -$16.13 |
Based on FMP financials and quantitative analysis
ASH Latest News
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
prnewswire.com · May 21, 2026
-
Reassessing Ashland (ASH) Valuation After Recent Share Price Weakness
Yahoo! Finance: ASH News · May 18, 2026
-
Ashland Board appoints Bertrand Loy as new director
globenewswire.com · May 18, 2026
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
gurufocus.com · May 15, 2026
ASH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ASH.
Price Targets
Consensus target: $68.29
ASH MoonshotScore
What does this score mean?
The MoonshotScore rates ASH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
Reassessing Ashland (ASH) Valuation After Recent Share Price Weakness
Ashland Board appoints Bertrand Loy as new director
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
Leadership: Guillermo Novo
Chairman and Chief Executive Officer
Guillermo Novo serves as the Chairman and Chief Executive Officer of Ashland Inc. He has extensive experience in the specialty chemicals industry, having held leadership positions at various global companies. Prior to joining Ashland, Novo served as the President and CEO of Versum Materials, a leading supplier of materials to the semiconductor industry. He holds a Ph.D. in Chemical Engineering from Auburn University and an MBA from the University of Michigan.
Track Record: Since becoming CEO of Ashland Inc., Guillermo Novo has focused on driving growth through innovation, strategic acquisitions, and operational excellence. He has overseen the expansion of Ashland's Life Sciences and Personal Care segments, capitalizing on secular trends in healthcare and consumer preferences for sustainable products. Novo has also emphasized sustainability and environmental responsibility, positioning Ashland as a leader in sustainable specialty chemicals.
Common Questions About ASH (Basic Materials)
What does Ashland Inc. do?
Ashland Inc. is a global specialty chemicals company that develops, manufactures, and markets additives and specialty ingredients. The company operates through four segments: Life Sciences, Personal Care & Household, Specialty Additives, and Intermediates and Solvents. Ashland's products are used in a wide range of applications, including pharmaceuticals, personal care products, coatings, construction materials, and industrial processes. The company's business model focuses on providing tailored solutions to customers in diverse end markets, leveraging its expertise in specialty chemicals and additives.
What do analysts say about ASH stock?
Analyst coverage of Ashland Inc. (ASH) reflects a mixed outlook, with some focusing on the company's growth potential in key segments like Life Sciences and Personal Care, while others express concern over its profit margin. Key valuation metrics include price-to-earnings ratio, enterprise value-to-EBITDA, and dividend yield. Growth considerations center on Ashland's ability to capitalize on secular trends in healthcare and consumer preferences for sustainable products. Analyst consensus typically provides price targets and ratings based on these factors, but it is important to conduct independent research before making investment decisions.
What are the main risks for ASH?
Ashland Inc. faces several risks, including economic downturns affecting demand in key end markets, raw material price volatility impacting profitability, increased competition from existing and new players in the specialty chemicals industry, changes in environmental regulations increasing compliance costs, and disruptions in supply chains affecting production and distribution. The company's negative profit margin of -39.0% also poses a significant risk, requiring management to improve operational efficiency and cost control. Effective risk management strategies are crucial for Ashland to mitigate these challenges and sustain long-term growth.
What are the key factors to evaluate for ASH?
Ashland Inc. (ASH) holds an AI score of 49/100 (low). P/E: 12.8x vs the S&P 500's ~20-25x. Analysts target $68.29 (+2%). Not financial advice.
How frequently does ASH data refresh on this page?
ASH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ASH's recent stock price performance?
Ashland Inc. (ASH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio catering to multiple end markets. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ASH overvalued or undervalued right now?
Ashland Inc. (ASH) trades at 12.8x earnings. Analysts target $68.29 (+2%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ASH?
Before investing in Ashland Inc. (ASH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on thorough research and consultation with a financial advisor.